| Document |
Document Title |
|
WO/2024/074864A1 |
The claimed invention provides recipes for preparing just one beverage using two sweeteners, D-Tagatose and Monk Fruit, a flavor consisting of pure six natural essential oils, a natural enhancer, a functional natural ingredient of Americ...
|
|
WO/2024/074835A1 |
The present disclosure relates to an oral product, a process for producing the oral product, as well as to uses of said oral product. The oral product includes caffeine, a combination of B vitamins comprising at least vitamin B1, vitamin...
|
|
WO/2024/075024A1 |
This invention relates to methods for purifying type II collagen from cartilage tissue. The present invention also relates to a type II collagen composition, and the use of the type II collagen composition as a dietary supplement or trea...
|
|
WO/2024/075706A1 |
A ruminant methane production inhibitor according to the present invention is characterized by containing, as active ingredients, cashew nut shell oil, heat-treated cashew nut shell oil, anacardic acid, cardanol and/or cardol, and an org...
|
|
WO/2024/075085A1 |
The disclosure provided herein is related to the use of a methylotrophic yeast and its derivatives as a food additive and source of flavoring compounds.
|
|
WO/2024/076509A1 |
A process and system for producing a nutrient supplement from an anaerobic fermentation process comprising fermenting in a gaseous substrate with an acetogenic culture. The process comprises recovering an oxygenated hydrocarbon and incub...
|
|
WO/2024/074746A1 |
The present invention relates to a high protein vegan ice cream comprising: (a) a vegan ice cream base; and (b) extruded plant protein, wherein the total protein content in the vegan ice cream is at least 6 g per 100 g of ice cream, and ...
|
|
WO/2024/076523A1 |
The present invention is directed to an agricultural mixture comprising 1-amino-1-cyclopropanecarboxylic acid, a hydrate thereof, a polymorph thereof or a salt thereof and jasmonic acid. The present invention is further directed to a met...
|
|
WO/2024/075330A1 |
Provided is a method for improving the health condition of a mammal or a farm animal. The method for improving the health condition of a mammal or a farm animal comprises feeding a licorice root extract to the mammal or the farm animal, ...
|
|
WO/2024/075681A1 |
An oral composition that contains the following components (A), (B) and (C): (A) 10-20 mass % of chlorogenic acid, (B) 0.4-5 mass % of caffeine, and (C) 4-vinylguaiacol. The mass ratio [(C)/(B)] of component (C) and component (B) is 0.3 ...
|
|
WO/2023/230522A3 |
Some embodiments are directed to systems and methods for treating a viscous fluid. The viscous liquid may be a liquid sugar. The viscous fluid may have a viscosity of at least 50 cP. The system may include one or more mixers configured t...
|
|
WO/2024/076369A1 |
The improved process for infusion of flavors into delicate shrimp and other seafood and consumable protein products involves utilization of a tumbler device with a drum inner chamber having screw-type baffles, each baffle having a produc...
|
|
WO/2024/076349A1 |
A soft, shelf stable food product including a high protein matrix and particulates that retains a soft, moist eating experience over an extended shelflife is described. The high protein matrix includes hydrolyzed collagen and a soluble f...
|
|
WO/2024/074895A2 |
A gummy composition comprising at least 46 percent by weight of the composition of a protein, wherein at least a portion of the protein is hydrolized. A composition can include 47-57 grams protein-based gelatin; 28-43 grams water; 1-5 gr...
|
|
WO/2024/074839A1 |
The present disclosure relates to an oral product, a process for producing the oral product, as well as to uses of said oral product. The oral product is a solid in chewable form comprising a combination of active ingredients, wherein th...
|
|
WO/2024/075453A1 |
The present invention addresses the problem of providing: an Alzheimer-type dementia preventing agent which is safe and therefore can be ingested everyday, can be used as a health food, and can prevent Alzheimer-type dementia; and a meth...
|
|
WO/2024/074836A1 |
The present disclosure relates to an oral product, a process for producing the oral product, as well as to uses of said oral product. The oral product comprises a combination of active ingredients, wherein the combination comprises: caff...
|
|
WO/2024/075757A1 |
The purpose of the present invention is to provide an acidic seasoning that shows emulsion stability over a wide range of fat/oil content without using egg yolk or synthetic emulsifiers. The present inventors found that an acidic seasoni...
|
|
WO/2024/023582A3 |
Protein-enriched marshmallow formulations providing average adults with enough protein to maximize muscle-protein synthesis and nutritional ingestion processes for about 3-hour periods of time. Also, such marshmallows formulations can ef...
|
|
WO/2024/074843A1 |
The present disclosure relates to an oral product, a process for producing the oral product, as well as to uses of said oral product. The oral product is solid and in chewable form comprising a combination of active ingredients, wherein ...
|
|
WO/2024/076752A1 |
The present disclosure relates to a hypoallergenic nutritionally complete dry food composition for companion animals, particularly for puppies. The hypoallergenic nutritionally complete dry food composition for a puppy, wherein said comp...
|
|
WO/2024/074159A1 |
A method for preparing a small-molecule ass-hide glue polypeptide product. The method comprises the following steps: S1. pretreatment of ass-hide glue: crushing ass-hide glue blocks as raw materials, dissolving same by adding water, perf...
|
|
WO/2024/076288A1 |
An oil composition comprises from 1% to 20% by weight of caproic acid residues (C6:0); at least 55% by weight of C16 to C18 unsaturated fatty acid residues; and less than 40% by weight of C8 to C24 saturated fatty acid residues; wherein ...
|
|
WO/2024/076759A1 |
The present disclosure provides an animal food composition comprising hydrolyzed proteins, fructooligosaccharides (FOS), maize starch, omega- 3 fatty acids, omega-6 fatty acids, and 0.26 g/Mcal or less of zeolite by weight relative to th...
|
|
WO/2024/073844A1 |
According to embodiments, a modified freeze-drying apparatus and methods of use are provided herein for providing variable power heating for precise control of material temperatures during freeze-drying. The apparatus may provide a vacuu...
|
|
WO/2024/075625A1 |
Provided is a composition against visual field defect disorders, glaucoma, light-induced eye tissue disorders, and disorders related thereto that can be used as a food, beverage, or drug that can be taken over the long term for preventio...
|
|
WO/2024/075452A1 |
The purpose of the present invention is to provide: a modified-protein-reducing agent that is safe and can be taken at a daily dosage or used as a functional food, and that makes it possible to reduce the amount of a modified protein in ...
|
|
WO/2024/075891A1 |
The present invention relates to a nitric oxide donor transporter (NODT) possessing low molecular weight levan. More specifically, a nitric oxide donor transporter composition includes low molecular weight levan with a molecular weight (...
|
|
WO/2024/075835A1 |
The present invention provides a novel application for Nannochloropsis algae. Specifically, an aqueous extract of Nannochloropsis algae is used in suppressing any increase in body weight or inhibiting any acceleration in synthesis of cho...
|
|
WO/2024/054472A3 |
AC-11® is a federally registered trademark covering a product consisting of an aqueous extract of the botanical Uncaria tomentosa. Applicants have found that administration of AC- 11 ® product in a pharmaceutically effective amount and...
|
|
WO/2024/074589A1 |
The invention provides a plant-based cheese of the half-hard type comprising from 5 to 35 wt.% of a vegetable fat, from 20 to 40 wt.% (modified) starches; from 1 to 7 wt.% (phospholipid) w/o emulsifier, the remainder (up to 100 wt.%) bei...
|
|
WO/2024/074842A1 |
The present disclosure relates to an oral product, a process for producing the oral product, as well as to uses of said oral product. The oral product is solid and in chewable form comprising a combination of active ingredients, wherein ...
|
|
WO/2024/075680A1 |
An oral composition that contains the following components (A), (B) and (C): (A) 5-20 mass % of chlorogenic acid, (B) 0.001 mass % or more and less than 0.4 mass % of caffeine, and (C) 4-vinylguaiacol. The mass ratio [(C)/(B) ] of compon...
|
|
WO/2024/073850A1 |
Disclosed are methods and systems for degrading deoxynivalenol (DON) in cereal grains such as barley, using plasma activated water (PAW) in grain steeping to reduce the concentration of DON in cereal grains.
|
|
WO/2024/075721A1 |
The present invention addresses the problem of providing: a coffee containing a milk-derived ingredient and providing sensation of typical coffee's aroma and flavor; and a production method for the coffee. This production method is for...
|
|
WO/2024/026561A3 |
Disclosures herein relate to methods of producing oral powdered compositions for fecal microbiota transplant including desired microbes and related methods of treatment. Procedures for producing the powdered composition may include filte...
|
|
WO/2024/076330A1 |
The invention relates to a composition with antibacterial and antibiotic properties that can be used as a washing solution in wounds or infection areas, can be easily sprayed, prevents biofilm formation on the wound, and to the productio...
|
|
WO/2024/074834A1 |
The present disclosure relates to an oral product, a process for producing the oral product, as well as to uses of said oral product. The oral product includes L-theanine, ginseng and lemon balm.
|
|
WO/2024/075937A1 |
The present invention relates to a composition comprising a fucoidan fermentation product, and use thereof for improving the condition of the skin. Since low-molecular weight fucoidan can be induced when fucoidan is fermented using a Lac...
|
|
WO/2024/040205A3 |
The present invention provides a continuous process for the sterilization of a substrate. The process comprising a step of preparing a substrate mixture having a moisture content. A further step includes loading a carrier with the substr...
|
|
WO/2024/076911A1 |
Composite flour includes native plant flour and complexed MCT and/or other nutritional oil at least partially encapsulated by wall material and incorporated within the composite flour, wherein polysaccharide from a portion of the native ...
|
|
WO/2024/075701A1 |
Provided is a novel steviol glycoside-containing beverage having a favorable taste quality, or a production method therefor. The present invention provides a production method for a beverage, comprising: freezing at least one selected fr...
|
|
WO/2024/075067A1 |
The present invention relates to a compound selected from a polynucleotide coding for Glypican-1, a vector, and a host cell genetically engineered so as to express Glypican-1 The present invention further relates to the use of the compou...
|
|
WO/2024/075329A1 |
Provided is a licorice extract that can be used as a multi-functional raw material. This licorice extract contains: (A) one or more selected from the group consisting of glycyrrhizic acid, glycyrrhizic acid derivatives, glycyrrhetic acid...
|
|
WO/2024/076289A1 |
The present invention provides the use of Brevundimonas sp. as a probiotic supplement in shrimp farming. The benefits provided by this probiotic include gut microbiota stabilization, disease resistance improvement and shrimp nutritional ...
|
|
WO/2024/076917A1 |
Protein-complexed MCT oil includes MCT droplets or particles encapsulated by and/or complexed with protein-based wall material. Protein-complexed MCT oil can be used as an additive for food products. The wall material includes protein, e...
|
|
WO/2024/075892A1 |
The present invention relates to a big data- and AI-based plasma agricultural product storage system that can maintain the freshness of agricultural products and extend the storage period thereof by deriving optimal control values by col...
|
|
WO/2024/075794A1 |
Provided is a novel anti-influenza virus agent which inhibits the growth and infection mechanisms of influenza virus and thus has a target other than specific viral proteins and which does not cause the emergence of drug-resistant viruse...
|
|
WO/2024/076874A1 |
A transmission system for reducing decomposition of a perishable good, the system comprising one or more compositions, wherein the one or more compositions comprise at least one active compound, and at least one non-active compound, and ...
|
|
WO/2024/075683A1 |
An ice cream having a chlorogenic acid content of 0.01-1.50 mass%, wherein the ratio of the caffeine content to the chlorogenic acid content is 0.60 or less.
|
